20. Practical application of subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy – results from a multicenter, randomized, double-blind, placebo-controlled trial (The PATH Study). Issue 3 (March 2020) - Schaik, I.N.; Bril, V.; Geloven, N.; Hartung, H.P.; Lewis, R.A.; Sobue, G.; Lawo, J.P.; Mielke, O.; Durn, B.L.; Cornblath, D.R.; Merkies, I.S.J.; Dimachkie, M.M.; et al.